April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Analysis of Cellular Toxicity of a Thermal Gel for utilization as a Retinal Drug Delivery System
Author Affiliations & Notes
  • Veeral S. Shah
    University of Pittsburgh Ophthalmology, Eye and Ear Institute, Pittsburgh, Pennsylvania
  • Thomas Friberg
    University of Pittsburgh Ophthalmology, Eye and Ear Institute, Pittsburgh, Pennsylvania
  • James L. Funderburgh
    Department of Ophthalmology,
    University of Pittsburgh, Pittsburgh, Pennsylvania
  • Danny S. Roh
    Ophthal/Cell Biology/Eye & Ear Inst, Univ of Pittsburgh Sch of Med, Pittsburgh, Pennsylvania
  • Daewon Park
    Department of Bioengineering and the McGowan Institute for Regenerative Medicine,
    University of Pittsburgh, Pittsburgh, Pennsylvania
  • Yadong Wang
    Department of Bioengeneering and the McGowan Institute for Regenerative Medicine, University of Pittsburgh, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Footnotes
    Commercial Relationships  Veeral S. Shah, None; Thomas Friberg, None; James L. Funderburgh, None; Danny S. Roh, None; Daewon Park, None; Yadong Wang, None
  • Footnotes
    Support  P30 EY008098, Fox Center for Vision Restoration, Research to Prevent Blindness, and the Eye and Ear Foundation on all of your publications, abstracts.
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 6463. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Veeral S. Shah, Thomas Friberg, James L. Funderburgh, Danny S. Roh, Daewon Park, Yadong Wang; Analysis of Cellular Toxicity of a Thermal Gel for utilization as a Retinal Drug Delivery System. Invest. Ophthalmol. Vis. Sci. 2011;52(14):6463.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Reverse thermal gels are chemicals that readily dissolve in water and undergo phase transition to a hydrogel with changes in ambient temperature. Thermal gels can 1) be designed to undergo gelation at body temperature and 2) be modified to incorporate bio-molecules to guide cell interaction. Thus they have numerous biomedical implications including tissue engineering and drug delivery. In this study, we tested the toxic effects of a novel thermal gel Polyurethane/ Poly-ethylene-glycol (ESHU) on cultured bovine corneal endothelium cells by evaluating cell viability.

Methods: : Cultured monolayers of primary bovine corneal endothelium were exposed for 24 hours to one of the following 4 liquids: 1) Control (serum-free DMEM), 2) ESHU (15% dilution of DMEM), 3) perfluoron (PFO or perfluoro-n-octane) and 4) a 5000cs silicone oil. After at 1 hr, 12 hr, and 24 hrs viability of cultured corneal endothelium cells was evaluated by immunofluorescent microscopy after staining with Calcein AM, propidium iodide (PI), and Hoechst. Cytotoxicity was calculated as PI nuclei/total nuclei in three separate cultures. Cell morphology was also assessed by microscopy.

Results: : Cytotoxicity analysis demonstrated that there was no significant damage to cultured corneal endothelium cells by ESHU gel or PFO treatment compared to the control (P>0.05, two- way ANOVA) at each timepoint. Silicone oil treated cultures, however, demonstrated marked cell death at all timepoints when compared to controls (P<0.001, two- way ANOVA) and ESHU gel treatment cultures (P<0.001, two- way ANOVA), with nearly 75% cell death at 24 hours. Qualitatively, corneal endothelium cells treated with ESHU thermal gel for 48 hr showed no evidence of altered cellular morphology on microscopic examination.

Conclusions: : In this cell culture model, ESHU thermal gel appear safe with respect to limited contact with bovine corneal endothelium, and support a practical role for further investigations of thermal gels in drug delivery.

Keywords: cell survival • retina • cornea: endothelium 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×